Expertise in
3
conditions
Expertise in
3
conditions
Rome, IT 

Overview

Gerardo Palmisano practices practicing medicine in Rome, Italy.

Mr. Palmisano is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Discoid Lupus Erythematosus (DLE), Cutaneous Lupus Erythematosus (CLE), and Glycogen Storage Disease Type 6.

He is actively involved in clinical research, co-authoring 46 peer reviewed articles.

Gender

Male

Locations

Rome, Italy
Other Locations
Palermo, 90128, Italy

Frequently Asked Questions about Gerardo Palmisano

Is Gerardo Palmisano a top-rated expert for Basal Cell Skin Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Gerardo Palmisano is classified as an Distinguished expert for Basal Cell Skin Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gerardo Palmisano participate in research or clinical trials?

Yes. Gerardo Palmisano has published 46 articles and abstracts on conditions like Basal Cell Skin Cancer. You can view a list of Gerardo Palmisano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Palmisano's expertise for a condition
ConditionClose
    View All 37 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile